- Home
- BON vs CMND Comparison
BON vs CMND Comparison
Compare BON & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BON
- CMND
- Stock Information
- Founded
- BON 2006
- CMND 2017
- Country
- BON China
- CMND Canada
- Employees
- BON N/A
- CMND N/A
- Industry
- BON Medicinal Chemicals and Botanical Products
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- BON Health Care
- CMND Health Care
- Exchange
- BON Nasdaq
- CMND Nasdaq
- Market Cap
- BON 6.6M
- CMND 6.5M
- IPO Year
- BON 2021
- CMND N/A
- Fundamental
- Price
- BON $1.12
- CMND $1.29
- Analyst Decision
- BON
- CMND
- Analyst Count
- BON 0
- CMND 0
- Target Price
- BON N/A
- CMND N/A
- AVG Volume (30 Days)
- BON 23.4K
- CMND 91.1K
- Earning Date
- BON 02-28-2025
- CMND 04-15-2025
- Dividend Yield
- BON N/A
- CMND N/A
- EPS Growth
- BON N/A
- CMND N/A
- EPS
- BON 0.17
- CMND N/A
- Revenue
- BON $23,844,556.00
- CMND N/A
- Revenue This Year
- BON $223.38
- CMND N/A
- Revenue Next Year
- BON $18.82
- CMND N/A
- P/E Ratio
- BON $6.42
- CMND N/A
- Revenue Growth
- BON N/A
- CMND N/A
- 52 Week Low
- BON $1.07
- CMND $0.95
- 52 Week High
- BON $5.31
- CMND $2.30
- Technical
- Relative Strength Index (RSI)
- BON 33.73
- CMND 40.62
- Support Level
- BON $1.07
- CMND $1.35
- Resistance Level
- BON $1.36
- CMND $1.38
- Average True Range (ATR)
- BON 0.09
- CMND 0.09
- MACD
- BON -0.01
- CMND -0.01
- Stochastic Oscillator
- BON 18.28
- CMND 22.19
About BON Bon Natural Life Limited
Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from perfumes and fragrance products.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.